C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Clinical trials for C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS) explained in plain language.

Never miss a new study

Get alerted when new C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS) trials appear

Sign up with your email to follow new studies for C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Diabetes drug tested as potential new weapon against inherited ALS

Disease control Ongoing

This study is testing whether metformin, a common diabetes medication, is safe and tolerable for people with a specific genetic form of ALS caused by a C9orf72 mutation. Researchers want to see if taking metformin for 24 weeks can reduce levels of harmful proteins in the brain an…

Matched conditions: C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Get alerted when new C9ORF72 AMYOTROPHIC LATERAL SCLEROSIS (ALS) trials appear

Diabetes drug tested as potential new weapon against inherited ALS